December 17, 2024 - 13:10

Chrystia Freeland has announced her resignation from the position of Finance Minister, citing fundamental differences with Prime Minister Justin Trudeau regarding the future economic direction of Canada. Freeland expressed concerns particularly about the implications of increasing U.S. tariffs on Canadian goods, which she believes could have detrimental effects on the nation's economy.
In her statement, Freeland emphasized the importance of pursuing strategies that prioritize Canadian interests and protect the country's trade relationships. The disagreement reportedly stemmed from contrasting views on how to navigate the challenges posed by U.S. trade policies, with Freeland advocating for a more assertive approach to safeguard Canadian industries.
Her resignation marks a significant shift in the Trudeau administration, as Freeland has been a key figure in managing the country’s economic landscape, especially during the tumultuous period of the COVID-19 pandemic. The decision has raised questions about the government's future economic strategies and how it will address ongoing trade tensions with the United States.
May 9, 2026 - 22:04
Compass Diversified Q1 Earnings Call HighlightsCompass Diversified, the publicly traded holding company known as CODI, reported its first-quarter 2026 earnings this week, with management framing the period as one of disciplined execution. Chief...
May 9, 2026 - 00:34
Urbana Corporation Has Filed 2026 First Quarter Interim Financial StatementsTORONTO - Urbana Corporation has submitted its unaudited interim financial statements and management discussion for the first quarter of 2026. The filing covers the three-month period ending March...
May 8, 2026 - 11:59
Australia regulator calls for urgent cybersecurity action to counter MythosAustralia`s corporate watchdog has called on the country`s financial industry to take urgent steps to address cybersecurity risks posed by advanced artificial intelligence systems, including a...
May 7, 2026 - 20:22
IN8bio Reports First Quarter 2026 Financial Results and Recent Business HighlightsIN8bio, a clinical-stage biopharmaceutical company focused on gamma-delta T cell therapies, announced its financial results for the first quarter of 2026 along with key business updates. The...